XIIDRA IINSIDER
Dead / Cancelled — Cancelled — Section 8 (as of 08 Sept 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87078416
- Registration number
- 5152914
- Mark type
- Stylized text
- Filed
- 21 Jun 2016
- Published for opposition
- 08 Nov 2016
- Registered
- 28 Feb 2017
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 035 — Advertising and business services: Administration of a program for enabling participants to obtain savings on out-of-pocket costs associated with the purchase of prescription pharmaceuticals for treating dry eye disease
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information in the field of dry eye disease and its treatment
Owner
- NOVARTIS AG, BASEL, CH
- SARcode Bioscience Inc., Lexington, MA, US
- SARcode Bioscience Inc., Lexington, MA, US
- SARcode Bioscience Inc., Lexington, MA, US
Prosecution history
- 08 Sept 2023 — CANCELLED SEC. 8 (6-YR)
- 28 Feb 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Mar 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Mar 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Feb 2017 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jan 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jan 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jan 2017 — USE AMENDMENT FILED
- 21 Jan 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jan 2017 — TEAS STATEMENT OF USE RECEIVED
- 03 Jan 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT